β-Secretase is the enzyme responsible for the Amyloid-β plaques found in Alzheimer’s disease. Inhibition of this enzyme should prove to be very useful in combating Alzheimer’s disease by preventing this build-up. After a computational screening of the NCID-2 library a molecule was found to possess a 2- propanol structure with aromatic groups on either side. This moiety was replicated by a combinatorial library of 150 compounds. These compounds were screened initially against β-secretase at 100, 50, and then 25 μM to narrow down to 17 structures showing 50% inhibition at 25 μM. The IC50 for each of the 17 molecules was found experimentally resulting in one lead compound 15, 4.93 μM ± 0.86 μM. This compound was modified by making slight chang...
SummaryAlzheimer's disease (AD) is characterized pathologically by the abundance of senile plaques a...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (...
β-Secretase is the enzyme responsible for the Amyloid-β plaques found in Alzheimer’s disease. Inhibi...
Effective treatment of Alzheimer's disease (AD) remains a critical unmet need in medicine. The lack ...
The studies were carried out in collaboration with Siena Biotech and involve the identification of n...
The membrane-embedded γ-secretase complex carries out hydrolysis within the lipid bilayer in proteol...
SummaryDevelopment of disease-modifying therapeutics is urgently needed for treating Alzheimer disea...
Alzheimer's disease (AD) is the most common form of dementia in the elderly with progressive cogniti...
Gamma-secretase is a trans-membrane aspartyl protease that consists of four subunits, namely Anterio...
The amyloid cascade hypothesis poses one possible explanation for the onset and progression of Alzhe...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, presenting itself clinical...
Alzheimer’s disease (AD) is the most common cause of dementia among older people, and the prevalence...
Development of disease-modifying therapeutics is urgently needed for treating Alzheimer disease (AD)...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
SummaryAlzheimer's disease (AD) is characterized pathologically by the abundance of senile plaques a...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (...
β-Secretase is the enzyme responsible for the Amyloid-β plaques found in Alzheimer’s disease. Inhibi...
Effective treatment of Alzheimer's disease (AD) remains a critical unmet need in medicine. The lack ...
The studies were carried out in collaboration with Siena Biotech and involve the identification of n...
The membrane-embedded γ-secretase complex carries out hydrolysis within the lipid bilayer in proteol...
SummaryDevelopment of disease-modifying therapeutics is urgently needed for treating Alzheimer disea...
Alzheimer's disease (AD) is the most common form of dementia in the elderly with progressive cogniti...
Gamma-secretase is a trans-membrane aspartyl protease that consists of four subunits, namely Anterio...
The amyloid cascade hypothesis poses one possible explanation for the onset and progression of Alzhe...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, presenting itself clinical...
Alzheimer’s disease (AD) is the most common cause of dementia among older people, and the prevalence...
Development of disease-modifying therapeutics is urgently needed for treating Alzheimer disease (AD)...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
SummaryAlzheimer's disease (AD) is characterized pathologically by the abundance of senile plaques a...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (...